Updated:
EDBI
EDBI is a Singapore-based private equity firm focused on venture capital in biomedical sciences and information technology.
EDBI
EDBI was established in 1991 as a private equity vehicle. No public disclosure identifies a founding principal or wealth source. The firm pursues venture capital across seed, early, and expansion stages. Asset classes include biotechnology, healthcare IT, software, and renewable energy. Geographic reach centers on Singapore and other Asian markets with additional global exposure. No named portfolio companies appear in available records. Team size and office locations beyond headquarters remain undisclosed. No adjacent vehicles or dated operational events from the last 24 months are documented. EDBI maintains a direct investment mandate without publicly disclosed fund vehicles or co-investment clubs.
General information
Firm type
Private Equity
Year founded
1991
AUM
Undisclosed
Location
Region
Asia
Country
Singapore
City
Singapore
Corporate office
250 North Bridge Road, #28-00 Raffles City Tower, Singapore
Sector focus
Frequently asked questions
Who runs investment decisions at EDBI?
No named principals or investment committee members are disclosed in public sources.
Does EDBI participate in fund commitments or only direct deals?
Available records indicate a focus on direct venture investments without reference to fund commitments.
What investment stages does EDBI typically target?
The firm covers seed through expansion and late stage as listed in its strategy profile.
Which sectors does EDBI explicitly avoid?
No avoidance list is published; documented activity spans biotechnology, healthcare, IT, and related fields.
Where does the underlying wealth come from?
No wealth-origin disclosure exists for EDBI.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: